TLE5

TLE family member 5, transcriptional modulator, the group of TLE family

Basic information

Region (hg38): 19:3052910-3063107

Previous symbols: [ "AES" ]

Links

ENSG00000104964NCBI:166OMIM:600188HGNC:307Uniprot:Q08117AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TLE5 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLE5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
4
clinvar
4
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 4 0 0

Variants in TLE5

This is a list of pathogenic ClinVar variants found in the TLE5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-3053896-C-T not specified Uncertain significance (Sep 25, 2023)3177828
19-3053974-C-T not specified Uncertain significance (Oct 25, 2023)3177827
19-3056347-T-C not specified Uncertain significance (Aug 17, 2022)3177826
19-3057742-G-A not specified Likely benign (May 14, 2024)3326302
19-3062727-C-G not specified Uncertain significance (Jul 09, 2021)3177825

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TLE5protein_codingprotein_codingENST00000221561 710198
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9360.064000000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.06781490.5250.000008251691
Missense in Polyphen1142.0360.26168514
Synonymous-1.288571.31.190.00000477533
Loss of Function3.10113.10.07615.64e-7154

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcriptional corepressor. Acts as dominant repressor towards other family members. Inhibits NF-kappa-B-regulated gene expression. May be required for the initiation and maintenance of the differentiated state. Essential for the transcriptional repressor activity of SIX3 during retina and lens development. {ECO:0000269|PubMed:10660609, ECO:0000269|PubMed:10748198}.;
Pathway
Androgen receptor signaling pathway;Ectoderm Differentiation;Degradation of beta-catenin by the destruction complex;Signaling by WNT;Signal Transduction;Repression of WNT target genes;AndrogenReceptor;Regulation of nuclear beta catenin signaling and target gene transcription;Presenilin action in Notch and Wnt signaling (Consensus)

Recessive Scores

pRec
0.168

Intolerance Scores

loftool
0.254
rvis_EVS
-0.27
rvis_percentile_EVS
33.97

Haploinsufficiency Scores

pHI
0.289
hipred
Y
hipred_score
0.722
ghis
0.605

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.496

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowMedium
Primary ImmunodeficiencyMediumLowMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Aes
Phenotype
craniofacial phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;skeletal system development;multicellular organism development;animal organ morphogenesis;negative regulation of gene expression;Wnt signaling pathway;cellular response to extracellular stimulus;negative regulation of protein binding;regulation of growth;negative regulation of transcription, DNA-templated;negative regulation of response to cytokine stimulus;response to interleukin-1;negative regulation of canonical Wnt signaling pathway;positive regulation of anoikis
Cellular component
nucleus;transcription factor complex
Molecular function
transcription corepressor activity;protein binding;repressing transcription factor binding